Weaver Consulting Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Weaver Consulting Group’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-166	Closed	-$19K	–	916
2020 Q3	$19K	Hold	166	–	–	0.01%	417
2020 Q2	$19K	Buy	166 +42	+34%	+$4.14K	0.01%	397
2020 Q1	$10K	Hold	124	–	–	0.01%	454
2019 Q4	$10K	Hold	124	–	–	0.01%	501
2019 Q3	$11K	Hold	124	–	–	0.01%	468
2019 Q2	$11K	Hold	124	–	–	0.01%	448
2019 Q1	$10K	Buy	+124	New	+$10.5K	﹤0.01%	952

Other funds holding XBI

Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $60.6B AUM 31.35% 1-Year Est. Return

Citigroup New York $157B AUM 32.99% 1-Year Est. Return

Bank of America

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return

Susquehanna International Group

Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return

Bank of Nova Scotia

Bank of Nova Scotia Toronto, Ontario, Canada $57.1B AUM 35.3% 1-Year Est. Return